Compare Suven Life Sciences with VENUS REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs VENUS REMEDIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE SCIENCES VENUS REMEDIES SUVEN LIFE SCIENCES/
VENUS REMEDIES
 
P/E (TTM) x -93.7 -14.9 - View Chart
P/BV x 1.5 1.0 147.6% View Chart
Dividend Yield % 1.6 0.0 -  

Financials

 SUVEN LIFE SCIENCES   VENUS REMEDIES
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-19
VENUS REMEDIES
Mar-18
SUVEN LIFE SCIENCES/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs338126 268.2%   
Low Rs16961 277.3%   
Sales per share (Unadj.) Rs52.1301.8 17.3%  
Earnings per share (Unadj.) Rs6.8-24.9 -27.5%  
Cash flow per share (Unadj.) Rs8.62.5 336.8%  
Dividends per share (Unadj.) Rs1.500-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs65.3293.3 22.3%  
Shares outstanding (eoy) m127.2812.34 1,031.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.90.3 1,569.9%   
Avg P/E ratio x37.1-3.8 -987.3%  
P/CF ratio (eoy) x29.636.7 80.5%  
Price / Book Value ratio x3.90.3 1,218.2%  
Dividend payout %22.00-   
Avg Mkt Cap Rs m32,2721,154 2,797.0%   
No. of employees `0001.10.9 117.0%   
Total wages/salary Rs m661393 168.2%   
Avg. sales/employee Rs Th6,132.24,026.1 152.3%   
Avg. wages/employee Rs Th611.1425.0 143.8%   
Avg. net profit/employee Rs Th803.5-331.8 -242.2%   
INCOME DATA
Net Sales Rs m6,6353,724 178.2%  
Other income Rs m24223 1,076.8%   
Total revenues Rs m6,8773,747 183.6%   
Gross profit Rs m1,604395 406.3%  
Depreciation Rs m221338 65.4%   
Interest Rs m38354 10.6%   
Profit before tax Rs m1,587-275 -576.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m71832 2,272.1%   
Profit after tax Rs m869-307 -283.3%  
Gross profit margin %24.210.6 228.1%  
Effective tax rate %45.2-11.5 -394.0%   
Net profit margin %13.1-8.2 -159.0%  
BALANCE SHEET DATA
Current assets Rs m6,2322,638 236.3%   
Current liabilities Rs m1,4902,305 64.7%   
Net working cap to sales %71.58.9 799.2%  
Current ratio x4.21.1 365.4%  
Inventory Days Days86135 63.8%  
Debtors Days Days8346 178.3%  
Net fixed assets Rs m4,0434,871 83.0%   
Share capital Rs m127123 103.2%   
"Free" reserves Rs m8,1833,496 234.1%   
Net worth Rs m8,3103,619 229.6%   
Long term debt Rs m181,374 1.3%   
Total assets Rs m10,3897,509 138.4%  
Interest coverage x43.10.2 19,332.3%   
Debt to equity ratio x00.4 0.6%  
Sales to assets ratio x0.60.5 128.8%   
Return on assets %8.70.6 1,383.1%  
Return on equity %10.5-8.5 -123.4%  
Return on capital %19.51.6 1,233.5%  
Exports to sales %00-   
Imports to sales %013.9 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA517 0.0%   
Fx inflow Rs m5,6220-   
Fx outflow Rs m1,799517 348.4%   
Net fx Rs m3,822-517 -740.0%   
CASH FLOW
From Operations Rs m356514 69.1%  
From Investments Rs m-279-123 226.3%  
From Financial Activity Rs m-225-387 58.2%  
Net Cashflow Rs m-1484 -3,528.6%  

Share Holding

Indian Promoters % 63.4 32.9 193.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.2 -  
FIIs % 0.0 0.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 66.4 55.0%  
Shareholders   37,287 20,121 185.3%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE SCIENCES With:   IPCA LABS  NOVARTIS  ALEMBIC PHARMA  PROCTER & GAMBLE HEALTH  SANOFI INDIA  

Compare SUVEN LIFE SCIENCES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Falls 471 Points, Nifty Ends Below 14,700; Tata Steel & JSW Steel Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

VENUS REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 11.1% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, VENUS REMEDIES has posted a net profit of Rs 104 m (down 11.1% YoY). Sales on the other hand came in at Rs 864 m (down 7.3% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SCIENCES SHARE PRICE


May 12, 2021 (Close)

TRACK SUVEN LIFE SCIENCES

  • Track your investment in SUVEN LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE SCIENCES

SUVEN LIFE SCIENCES - GSK PHARMA COMPARISON

COMPARE SUVEN LIFE SCIENCES WITH

MARKET STATS